Home » Topics » Regulatory

Regulatory
RSS

First approval for Cubicin, Cubist's once-daily antibiotic for skin and skin structure infections

Sep. 16, 2003

Depakote ER approved for pediatric epilepsy

Sep. 16, 2003

Benicar HCT now available in U.S.

Sep. 15, 2003

Abilify sNDA approved for maintaining stability in patients with schizophrenia

Sep. 12, 2003

Requip sNDA for restless legs syndrome filed

Sep. 12, 2003

Paxil CR approved for premenstrual dysphoric disorder

Sep. 4, 2003

New Zonegran dosage strengths approved

Sep. 3, 2003

Valtrex approved for reducing risk of spreading genital herpes

Sep. 3, 2003

Intravenous Nexium to be launched in Sweden

Sep. 3, 2003

Wellbutrin XL approved for major depressive disorder

Sep. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.